Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2026-04-28 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
2025年度利润分配的预案
Regulatory Filings Classification · 95% confidence The document is a temporary announcement (临时公告) from a company regarding its 2025 profit distribution plan. It details the board meeting resolution, the audited net profit figures, and the decision not to distribute dividends for the year 2025. The document includes financial data but is primarily an announcement of the profit distribution proposal and related explanations, not a full financial report or annual report. It also mentions that the proposal will be submitted to the shareholders' meeting for approval. The document length is 1872 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits best as a Regulatory Filing (RNS) because it is a regulatory announcement about profit distribution plans and related disclosures, not the full annual report or dividend notice itself.
2026-04-28 Chinese
2025年年度报告摘要
Annual Report Classification · 95% confidence The document is titled "成都市贝瑞和康基因技术股份有限公司2025年年度报告摘要" which translates to "Chengdu Berry Genomics Co., Ltd. 2025 Annual Report Summary." It contains detailed financial data for the year 2025, including total assets, net profit, earnings per share, and quarterly financial data. It also includes comprehensive business descriptions, company operations, industry context, shareholder information, and other detailed disclosures typical of an annual report. The document length is over 13,000 characters, indicating it is a substantive report rather than a brief announcement. There is no indication that this is merely a notice of report publication or a certification. Therefore, this document is the actual Annual Report (10-K equivalent) or its summary, which fits the definition of an Annual Report (10-K). FY 2025
2026-04-28 Chinese
关于持股5%以上股东权益变动触及1%整数倍的公告
Major Shareholding Notification Classification · 100% confidence The document is a formal announcement from a company disclosing a change in shareholding by a shareholder holding more than 5% of the company's shares. It details the shareholder's name, the number of shares changed, the percentage of total shares, the method of change (judicial forced sale), and confirms no change in control or adverse impact on the company. The document is titled as an announcement about a shareholder's equity change crossing a 1% threshold. This matches the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds. The document length is short (1986 characters), and it contains detailed shareholding change data, not just a reference or link to a report. Therefore, it is not a report publication announcement or regulatory filing. It is not related to board changes, dividends, earnings, or other categories. Hence, the correct classification is MRQ with high confidence.
2026-04-12 Chinese
关于持股5%以上股东所持部分股份被司法强制执行的提示性公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding a shareholder holding more than 5% of shares whose shares are subject to judicial forced execution due to a stock pledge default. It details the shareholder's identity, the number of shares involved, the legal basis for the forced sale, and the potential impact on the company. There are no financial statements, no management discussion of financial results, no earnings data, and no mention of a report being attached or published. The document is a regulatory announcement about a significant shareholder's shareholding status and legal enforcement action, which fits the category of Major Shareholding Notification (MRQ).
2026-04-01 Chinese
关于公司董事辞职暨更换第十届董事会审计委员会部分委员的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a company director and the replacement of members of the audit committee of the board. It details the resignation of Mr. Zhao Hui from the board and audit committee, the election of a new audit committee member, and compliance with relevant laws and company regulations. There is no financial data, earnings information, or report publication mentioned. The content clearly relates to changes in the company's board and senior management structure. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and focused on management changes, not a full report or announcement of a report publication.
2026-03-22 Chinese
第十届董事会第二十次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the 20th meeting of the 10th Board of Directors of the company. It details the meeting attendance, the approval of changes in the Audit Committee members, and confirms compliance with legal and procedural requirements. There is no financial data, no detailed report, and no mention of an annual or interim report. The content focuses on board/management changes, specifically the appointment of a new Audit Committee member. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and it is not a report publication announcement or certification. Hence, the classification is MANG with high confidence.
2026-03-22 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.